Volunteer donor apheresis

Therapeutic Apheresis

Volumn 6, Issue 1, 2002, Pages 77-81

  Waxman, Dan A ^a  

^a Central Indiana Regional Blood Center   (United States)

Author keywords

Blood collection; Blood products; Donor apheresis; Multicomponent apheresis

Indexed keywords

APHERESIS; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BODY WEIGHT; ERYTHROCYTE; HUMAN; PLASMA; PLASMAPHERESIS; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE COUNT;

BLOOD COMPONENT REMOVAL; BLOOD DONORS; HUMANS; UNITED STATES;

EID: 0036124552     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2002.00395.x     Document Type: Article

References (50)

1. Plasma removal with return of corpuscles
2. Introduction to apheresis donations including history and general principles
3. Collection and transfusion of blood and blood components in the United States, 1994
4. New beginnings: The National Blood Data Resource Center
5. Lowering the hemoglobin cutoff for female plateletpheresis donors
6. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator
7. Transfusion-related acute lung injury: A neglected, serious complication of hemotherapy
8. Prevalence of HLA sensitization in female apheresis donors
9. Matching blood donations to type-specific product needs: A recruitment technique
10. A statistical model for estimating donor postdonation platelet counts after plateletpheresis
11. Economic impact of donor platelet count and platelet yield in apheresis products: Relevance for emerging issues in platelet transfusion therapy
12. Apheresis platelets: Emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion dose
13. Pooled platelet concentrates: Maybe not fancy, but fiscally sound and effective
14. Single donor platelets: Can we afford to use them? Can we afford not to use them?
15. Two-unit red cell apheresis and its potential advantages over traditional whole-blood donation
16. Red cell collection by apheresis technology
17. Comparison of in vivo red cell survival of donations collected by Haemonetics MCS versus conventional collection
18. Automated blood component collection with the MC3 3p cell separator: Evaluation of three protocols for buffy coat-poor and white cell-reduced packed red cells and plasma
19. Comparison of COBE white cell-reduction and standard plateletpheresis protocols in the same donors
20. Red blood cells, plasma, and other new apheresis-derived blood products: Improving product quality and donor utilization
21. A feasibility evaluation of an automated blood component collection system platelets and red cells
22. A new apheresis procedure for the preparation of high-quality red cells and plasma
23. Prospective comparison of plateletpheresis using four apheresis systems on the same donors
24. Evaluation of efficacy in platelet collection by the Haemonetics Component Collection System
25. Standarized units of RBCs: Is it time for implementation?
26. Comparison of a new WBC-reduction system and the standard plateletpheresis protocol in the same donors
27. Risks and safety practices in hemapheresis procedures
28. Mechanisms of adverse effects during hemapheresis
29. Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program
30. Effects on donors of repeated leukocyte losses during plateletpheresis
31. Effect of long-term platelet donation on lymphocyte subsets and plasma protein concentrations
32. Markers of haemostatic activation before and after blood donation and plasmapheresis
33. Automated plateletpheresis does not cause an increase in platelet activation in volunteer donors
34. Increase in endogenous thrombopoietin in healthy donors after automated plateletpheresis
35. Repeat plateletpheresis: The effects on the donor and the yield
36. Pseudothrombocytopenia in plateletpheresis donors
37. Clinical evaluation of repeat apheresis donors in Japan
38. Strategies to recruit plateletpheresis donor from a registry of HLA-typed, unrelated, bone marrow donors
39. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates
40. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets
41. Comparison of demographics and motivations of highly committed whole blood and platelet donors
42. Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: A comparison of apheresis and whole-blood donors. The retrovirus Epidemiology Donor study
43. Treatment of congenital afibrinogenemia with cryoprecipitate collected through a plasmapheresis program using dedicated donors
44. Concurrent comparison of the safety of paid cytapheresis and volunteer whole-blood donors
45. Monetary compensation for plasma donors: A record of safety
46. A blood center's motivation toward total apheresis collection